ATE214927T1 - Hemmung der symptome des prämenstruellen synchroms/dysphorische erkrankungen der späten lutealen phase - Google Patents
Hemmung der symptome des prämenstruellen synchroms/dysphorische erkrankungen der späten lutealen phaseInfo
- Publication number
- ATE214927T1 ATE214927T1 AT94309466T AT94309466T ATE214927T1 AT E214927 T1 ATE214927 T1 AT E214927T1 AT 94309466 T AT94309466 T AT 94309466T AT 94309466 T AT94309466 T AT 94309466T AT E214927 T1 ATE214927 T1 AT E214927T1
- Authority
- AT
- Austria
- Prior art keywords
- premenstrual
- synchrome
- dysphoric
- diseases
- luteal phase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/171,148 US5389670A (en) | 1993-12-21 | 1993-12-21 | Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE214927T1 true ATE214927T1 (de) | 2002-04-15 |
Family
ID=22622728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94309466T ATE214927T1 (de) | 1993-12-21 | 1994-12-19 | Hemmung der symptome des prämenstruellen synchroms/dysphorische erkrankungen der späten lutealen phase |
Country Status (18)
Country | Link |
---|---|
US (2) | US5389670A (de) |
EP (1) | EP0659412B1 (de) |
JP (1) | JPH07196503A (de) |
KR (1) | KR950016737A (de) |
CN (1) | CN1108255A (de) |
AT (1) | ATE214927T1 (de) |
AU (1) | AU8155994A (de) |
CA (1) | CA2138505A1 (de) |
CZ (1) | CZ321894A3 (de) |
DE (1) | DE69430232T2 (de) |
DK (1) | DK0659412T3 (de) |
ES (1) | ES2170767T3 (de) |
HU (1) | HUT71338A (de) |
IL (1) | IL112054A0 (de) |
NO (1) | NO944921L (de) |
PT (1) | PT659412E (de) |
RU (1) | RU94044488A (de) |
ZA (1) | ZA9410077B (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5811447A (en) * | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6395494B1 (en) | 1993-05-13 | 2002-05-28 | Neorx Corporation | Method to determine TGF-β |
US6251920B1 (en) | 1993-05-13 | 2001-06-26 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
US5770609A (en) | 1993-01-28 | 1998-06-23 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
US5595722A (en) * | 1993-01-28 | 1997-01-21 | Neorx Corporation | Method for identifying an agent which increases TGF-beta levels |
US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
CA2162586C (en) * | 1993-05-13 | 2006-01-03 | David J. Grainger | Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells |
US6197789B1 (en) | 1995-06-07 | 2001-03-06 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
US6417198B1 (en) | 1993-12-21 | 2002-07-09 | Eli Lilly And Company | Methods of inhibiting CNS problems in post-menopausal women |
US20030083733A1 (en) * | 1997-10-10 | 2003-05-01 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5514704A (en) * | 1995-03-13 | 1996-05-07 | Eli Lilly And Company | Benzothiophenes to inhibit leukotrienes |
US20020091433A1 (en) * | 1995-04-19 | 2002-07-11 | Ni Ding | Drug release coated stent |
US5837313A (en) * | 1995-04-19 | 1998-11-17 | Schneider (Usa) Inc | Drug release stent coating process |
US6099562A (en) * | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
IL120266A (en) | 1996-02-28 | 2005-05-17 | Pfizer | Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions |
IL120262A (en) * | 1996-02-28 | 2001-01-28 | Pfizer | Droloxifene and derivatives thereof for use in increasing serum testosterone levels |
US5985932A (en) * | 1996-02-28 | 1999-11-16 | Pfizer Inc | Inhibition of autoimmune diseases |
TW442286B (en) * | 1996-02-28 | 2001-06-23 | Pfizer | New therapeutic uses of estrogen agonists |
US5733937A (en) * | 1996-02-28 | 1998-03-31 | Pfizer Inc. | Methods for alleviating symptoms of premenstrual syndrome and late luteal phase dysphoric disorder |
US6110942A (en) * | 1996-06-17 | 2000-08-29 | Eli Lilly And Company | Method for minimizing the uterotrophic effect of droloxifene |
ZA982877B (en) * | 1997-04-09 | 1999-10-04 | Lilly Co Eli | Treatment of central nervous system disorders with selective estrogen receptor modulators. |
WO1998046588A2 (en) * | 1997-04-11 | 1998-10-22 | Neorx Corporation | Compounds and therapies for the prevention of vascular and non-vascular pathologies |
US6008232A (en) * | 1997-08-20 | 1999-12-28 | Eli Lilly And Company | Methods for preventing headaches |
US6096781A (en) | 1997-11-14 | 2000-08-01 | Eli Lilly And Company | 2-arylbenzo[B]thiophenes useful for the treatment of estrogen deprivation syndrome |
US6288108B1 (en) | 1998-06-16 | 2001-09-11 | Eli Lilly And Company | Methods for increasing levels of acetylcholine |
JP2002518329A (ja) | 1998-06-16 | 2002-06-25 | イーライ・リリー・アンド・カンパニー | アセチルコリンレベルを増加させる方法 |
US6258826B1 (en) | 1998-10-13 | 2001-07-10 | Eli Lilly And Company | Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndrome |
US6613083B2 (en) * | 2001-05-02 | 2003-09-02 | Eckhard Alt | Stent device and method |
WO2006072959A1 (en) * | 2005-01-10 | 2006-07-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Aqueous-based dispersions of metal nanoparticles |
ES2967484T3 (es) * | 2019-08-26 | 2024-04-30 | Period Pill Bv | Tratamiento de los síntomas inducidos por el ciclo menstrual |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
US4380635A (en) * | 1981-04-03 | 1983-04-19 | Eli Lilly And Company | Synthesis of acylated benzothiophenes |
US5075321A (en) * | 1987-03-24 | 1991-12-24 | University Of Pennsylvania | Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes |
US5395842A (en) * | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
JP3157882B2 (ja) * | 1991-11-15 | 2001-04-16 | 帝国臓器製薬株式会社 | 新規なベンゾチオフエン誘導体 |
-
1993
- 1993-12-21 US US08/171,148 patent/US5389670A/en not_active Expired - Fee Related
-
1994
- 1994-08-29 US US08/297,350 patent/US5550150A/en not_active Expired - Fee Related
- 1994-12-19 DE DE69430232T patent/DE69430232T2/de not_active Expired - Fee Related
- 1994-12-19 KR KR1019940034928A patent/KR950016737A/ko not_active Application Discontinuation
- 1994-12-19 ES ES94309466T patent/ES2170767T3/es not_active Expired - Lifetime
- 1994-12-19 JP JP6314600A patent/JPH07196503A/ja active Pending
- 1994-12-19 AU AU81559/94A patent/AU8155994A/en not_active Abandoned
- 1994-12-19 IL IL11205494A patent/IL112054A0/xx unknown
- 1994-12-19 HU HU9403671A patent/HUT71338A/hu unknown
- 1994-12-19 ZA ZA9410077A patent/ZA9410077B/xx unknown
- 1994-12-19 AT AT94309466T patent/ATE214927T1/de not_active IP Right Cessation
- 1994-12-19 NO NO944921A patent/NO944921L/no unknown
- 1994-12-19 CA CA002138505A patent/CA2138505A1/en not_active Abandoned
- 1994-12-19 DK DK94309466T patent/DK0659412T3/da active
- 1994-12-19 CZ CZ943218A patent/CZ321894A3/cs unknown
- 1994-12-19 CN CN94119273A patent/CN1108255A/zh active Pending
- 1994-12-19 PT PT94309466T patent/PT659412E/pt unknown
- 1994-12-19 RU RU94044488/14A patent/RU94044488A/ru unknown
- 1994-12-19 EP EP94309466A patent/EP0659412B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CZ321894A3 (en) | 1995-09-13 |
ZA9410077B (en) | 1996-06-19 |
EP0659412A3 (de) | 1995-09-06 |
RU94044488A (ru) | 1996-10-20 |
NO944921D0 (no) | 1994-12-19 |
US5550150A (en) | 1996-08-27 |
HUT71338A (en) | 1995-11-28 |
EP0659412B1 (de) | 2002-03-27 |
US5389670A (en) | 1995-02-14 |
CN1108255A (zh) | 1995-09-13 |
ES2170767T3 (es) | 2002-08-16 |
CA2138505A1 (en) | 1995-06-22 |
PT659412E (pt) | 2002-08-30 |
DE69430232D1 (de) | 2002-05-02 |
DE69430232T2 (de) | 2002-11-14 |
AU8155994A (en) | 1995-06-29 |
JPH07196503A (ja) | 1995-08-01 |
IL112054A0 (en) | 1995-03-15 |
EP0659412A2 (de) | 1995-06-28 |
DK0659412T3 (da) | 2002-06-17 |
NO944921L (no) | 1995-06-22 |
KR950016737A (ko) | 1995-07-20 |
HU9403671D0 (en) | 1995-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE214927T1 (de) | Hemmung der symptome des prämenstruellen synchroms/dysphorische erkrankungen der späten lutealen phase | |
NO20002440D0 (no) | Hydroksam- og karboksylsyrederivater med MMP- og TNF- inhiberende aktivitet | |
CO5280078A1 (es) | Compuestos | |
ATE153240T1 (de) | Behandlung peri-menopausaler syndrome | |
DE69427800D1 (de) | Methode zur Hemmung der Endometriose | |
NO944919L (no) | Fremgangsmåte for å inhibere atrofi av huden eller vagina | |
DK599789D0 (da) | 3,5-di-tertiaer-butyl-4-hydroxyphenyl-1,3,4-thiadazoler og -oxadiazoler samt 3,5-di-tertiaer-butyl-4-hydroxyphenyl-1,2,4-thiadazoler, -oxadiazoler og -triazoler som anti-inflammatoriske midler | |
ATE216582T1 (de) | Hemmung uteriner fibrose | |
ATE168887T1 (de) | Hemmung von dysfunctionalen uterusblutungen | |
YU30292A (sh) | Nova aktivna jedinejnja | |
DE69428877D1 (de) | Hemmung einer Fehlentwicklung der Ovarien, verspüteter Pubertät oder sexuellem Infantilismus | |
RU94045271A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера | |
EA199800015A1 (ru) | Способ ингибирования меланомы | |
ATE46332T1 (de) | Spiro-imidazolidine als aldose-reduktaseinhibitoren. | |
PL322872A1 (en) | Novel triazolones - inhibitors of b apolipoprotein synthesis | |
UA26459C2 (uk) | Іhгібітор впливу амілоїдhих білків | |
ES2041679T3 (es) | Compuestos analgesicos de octohidroindolizinas 5-substituidas y productos intermedios 7-ceto. | |
DE69808326D1 (de) | Azetidinonderivate zur behandlung von hcmv entzündungen | |
NO924806D0 (no) | Etanoladdukter av 6-sulfonylsubstituerte 3-hydroksykromaner og deres anvendelse som inhalasjonsmiddel ved sykdommer | |
DK0413278T3 (da) | Anvendelse af xanthinderivater mod mavesår | |
ES2037825T3 (es) | Uso farmaceutico de tioeteres aromaticos. | |
FR2226163A2 (en) | 2-Amino-5-methyl-4-phenyl-1-pyrrolines - with antidepressant and antiarrhythmic activity | |
TH23898B (th) | วิธีการหยุดยั้งการออกฤทธิ์ของ il-6 | |
SU770025A1 (ru) | 2-(Карбалкоксифениламино)-4,6-диарилпиримидины, проявляющие анальгетическую активность | |
NO942350L (no) | Peptidforbindelse med terapeutisk aktivitet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |